- Home
- FBRX vs MRBK Comparison
FBRX vs MRBK Comparison
Compare FBRX & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- MRBK
- Stock Information
- Founded
- FBRX N/A
- MRBK 2004
- Country
- FBRX United States
- MRBK United States
- Employees
- FBRX N/A
- MRBK N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- MRBK Major Banks
- Sector
- FBRX Health Care
- MRBK Finance
- Exchange
- FBRX Nasdaq
- MRBK Nasdaq
- Market Cap
- FBRX 154.5M
- MRBK 162.3M
- IPO Year
- FBRX N/A
- MRBK 2017
- Fundamental
- Price
- FBRX $12.94
- MRBK $14.29
- Analyst Decision
- FBRX Strong Buy
- MRBK Buy
- Analyst Count
- FBRX 3
- MRBK 2
- Target Price
- FBRX $68.00
- MRBK $17.50
- AVG Volume (30 Days)
- FBRX 94.9K
- MRBK 55.2K
- Earning Date
- FBRX 11-13-2025
- MRBK 10-23-2025
- Dividend Yield
- FBRX N/A
- MRBK 3.50%
- EPS Growth
- FBRX N/A
- MRBK 75.95
- EPS
- FBRX N/A
- MRBK 1.77
- Revenue
- FBRX N/A
- MRBK $109,758,000.00
- Revenue This Year
- FBRX N/A
- MRBK $25.14
- Revenue Next Year
- FBRX N/A
- MRBK $8.08
- P/E Ratio
- FBRX N/A
- MRBK $8.08
- Revenue Growth
- FBRX N/A
- MRBK 18.84
- 52 Week Low
- FBRX $4.11
- MRBK $11.16
- 52 Week High
- FBRX $28.68
- MRBK $17.33
- Technical
- Relative Strength Index (RSI)
- FBRX 49.05
- MRBK 40.73
- Support Level
- FBRX $11.00
- MRBK $14.62
- Resistance Level
- FBRX $15.01
- MRBK $15.15
- Average True Range (ATR)
- FBRX 1.15
- MRBK 0.57
- MACD
- FBRX 0.01
- MRBK -0.02
- Stochastic Oscillator
- FBRX 48.82
- MRBK 24.24
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.